Societies

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Societies

New Study Shows HPV Vaccination Significantly Reduces Prevalence of High-Risk HPV Infections in Rwanda

Photo: IARC/Linkedin

Jun 2, 2023, 05:54

New Study Shows HPV Vaccination Significantly Reduces Prevalence of High-Risk HPV Infections in Rwanda

IARC, the Ministry of Health of Rwanda, and their partners. “New study from IARC, the Ministry of Health of Rwanda, & partners shows vaccination against human papillomavirus HPV more than halved prevalence of infection with high-risk HPV types in country in less than 8 yrs.” The Lancet Global Health.

Source: IARC/Linkedin

HPV IARC Lancet Global Health Ministry of Health of Rwanda

Sep 5, 2024, 00:05

September is Gynecologic Cancer Awareness Month - NRG Oncology

Sep 5, 2024, 00:05

The International Myeloma Foundation has helped bring over 17 treatments for multiple myeloma to market

Sep 5, 2024, 00:02

Submit your clinical trials - ESTRO

Sep 5, 2024, 00:01

NCI's Rare Tumor Clinics bring pediatric patients and families with researchers and physicians to learn more, provide treatment recommendations, and accelerate progress

Sep 5, 2024, 00:01

Inequitable access to vaccines and high-performance screening tools accounts for the highest rates of new cases and deaths due to cervical cancer in the African region

Sep 5, 2024, 00:01

IARC is highlighting research areas scientists are working in to mark Childhood Cancer Awareness Month

Sep 4, 2024, 23:56

Honoring Gina Lee, Assistant Professor at UCI

Sep 4, 2024, 23:51

A life should be long - Children's Cancer Institute

Sep 4, 2024, 23:03

New episodes of the N.U.R.T.U.R.E. Podcast Series, presented by EONS, are now available

Sep 4, 2024, 18:10

Kashyap Patel: Our third annual gala to underscore the significance of collaboration in cancer care

Sep 4, 2024, 18:04

Darolutamide, enzalutamide, and apalutamide in Non-metastatic Castration-Resistant Prostate Cancer

Sep 4, 2024, 17:52

Ryan Fitzpatrick: The 6th annual MPN MDS EU Focus meeting by MD Education